5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites

Proceedings of the National Academy of Sciences of the United States of America

Volumn 95, Issue 2, 1998, Pages 735-740

  Jakab, Robert L ^a   Goldman Rakic, Patricia S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clozapine; Dorsolateral prefrontal cortex; Inhibitory interneuron; Macaque monkey; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; SEROTONIN RECEPTOR; CLOZAPINE; SEROTONIN 2A RECEPTOR;

ANIMAL; ARTICLE; BRAIN CORTEX; DENDRITE; DRUG EFFECT; MACACA; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PYRAMIDAL NERVE CELL; ANIMAL TISSUE; INTERNEURON; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RECEPTOR DENSITY; RHESUS MONKEY; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; DENDRITES; HALLUCINOGENS; MACACA MULATTA; PYRAMIDAL CELLS; RECEPTORS, SEROTONIN;

EID: 0031594813     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.95.2.735     Document Type: Article

References (51)

1. Aghajanian, G. K. (1995) in Psychopharmacology: The Fourth Generation of Progress, eds. Bloom, F. E. & Kupfer, D. J. (Raven, New York), pp. 451-460.
2. Buhot, M.-C. (1997) Curr. Opin. Neurobiol. 7, 243-254.
3. Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S. & Charney, D. S. (1991) Schizophr. Res. 4, 121-156.
4. Meltzer, H. Y. & Nash, J. F. (1991) Pharmacol. Rev. 43, 587-604.
5. Schmidt, C. J., Sorensen, S. M., Kehne, J. H., Carr, A. A. & Palfreyman, M. G. (1995) Life Sci. 56, 2209-2222.
6. Burnet, P. W., Chen, C. P., McGowan, S., Franklin, M. & Harrison, P. J. (1996) Neuroscience 73, 531-540.
7. Sanders-Bush, E. & Conn, P. J. (1986) Psychopharmacol. Bull. 22, 829-836.
8. Pompeiano, M., Palacios, J. M. & Mengod, G. (1994) Mol. Brain Res. 23, 163-178.
9. Wright, D. E., Seroogy, K. B., Lundgren, K. H., Davis, B. M. & Jennes, L. (1995) J. Comp. Neurol. 351, 357-373.
10. Pazos, A., Cortes, R. & Palacios, J. M. (1985) Brain Res. 346, 231-249.
11. Burnet, P. W., Eastwood, S. L., Lacey, K. & Harrison, P. J. (1995) Brain Res. 676, 157-168.
12. Pasqualetti, M., Nardi, I., Ladinsky, H., Marazziti, D. & Cassano, G. B. (1996) Brain Res. Mol. Brain Res. 39, 223-233.
13. Slater, P. & Patel, S. (1983) Eur. J. Pharmacol. 92, 297-298.
14. Blue, M. E., Yagaloff, K. A., Mamounas, L. A., Hartig, P. R. & Molliver, M. E. (1988) Brain Res. 453, 315-328.
15. Schotte, A. & Leyson, J. E. (1989) Eur. J. Pharmacol. 172, 99-106.
16. Appel, N. M., Mitchell, W. M, Garlick, R. K., Glennon, R. A., Teitler, M. & DeSouza, E. B. (1990) J. Pharmacol. Exp. Ther. 255, 843-857.
17. Rahman, S., McLean, J. H., Darby-King, A., Paterno, G., Reynolds, J. N. & Neumann, R. S. (1995) Neuroscience 66, 891-901.
18. Lidow, M. S., Goldman-Rakic, P. S., Gallager, D. W. & Rakic, P. (1989) J. Comp. Neurol. 280, 27-42.
19. Morilak, D. A., Garlow, S. J. & Ciaranello, R. D. (1993) Neuroscience 54, 701-717.
20. Willins, D. L., Deutsch, A. Y. & Roth, B. L. (1997) Synapse 27, 79-82.
21. Araneda, R. & Andrade, R. (1991) Neuroscience 40, 399-412.
22. Aghajanian, G. K. & Marek, G. J. (1997) Neuropharmacology 36, 589-599.
23. Sheldon, P. W. & Aghajanian, G. K. (1990) Brain Res. 506, 62-69.
24. Gellman, R. L. & Aghajanian, G. K. (1993) Brain Res. 600, 63-73.
25. Marek, G. J. & Aghajanian, G. K. (1996) J. Pharmacol. Exp. Ther. 278, 1373-1382.
26. Hancock, M. B. (1982) J. Histochem. Cytochem. 30, 578-579.
27. Brodmann, K. (1905) J. Psychol. Neurol. 4, 177-226.
28. Walker, A. E. (1940) J. Comp. Neurol. 73, 59-86.
29. Campbell, M. J. & Morrison, J. H. (1989) J. Comp. Neurol. 282, 191-205.
30. Hayes, T. L. & Lewis, D. A. (1992) Cerebral Cortex 2, 56-67.
31. Conde, F., Lund, J. S., Jacobowitz, D. M., Baimbridge, K. G. & Lewis, D. A. (1994) J. Comp. Neurol. 341, 95-116.
32. Jakab, R. L., Goldman-Rakic, P. S. & Leranth, C. (1997) Cerebral Cortex 7, 359-373.
33. Francis, P. T., Pangalos, M. N., Pearson, R. C. A., Middlemiss, D. N., Stratmann, G. C. & Bowen, D. M. (1992) J. Pharmacol. Exp. Ther. 261, 1273-1281.
34. Morilak, D. A., Somogyi, P., Lujan-Miras, R. & Ciaranello, R. D. (1994) Neuropsychopharmacology 11, 157-166.
35. Sloper, J. J. & Powell, T. P. S. (1978) Philos. Trans. R. Soc. London Ser. B. 285, 199-226.
36. Winfield, D. A., Rivera-Dominguez, M. & Powell, T. P. S. (1982) Brain Res. 231, 19-32.
37. Smiley, J. & Goldman-Rakic, P. S. (1996) J. Comp. Neurol. 367, 431-443.
38. de Lima, A. D., Bloom, F. E. & Morrison, J. H. (1988) J. Comp. Neurol. 274, 280-294.
39. Pazos, A., Probst, A. & Palacios, J. M. (1987) Neuroscience 21, 123-139.
40. Jakab, R. L., Hazrati, L.-N. & Goldman-Rakic, P. S. (1996) J. Comp. Neurol. 369, 137-149.
41. Schwindt, P. C. & Crill, W. E. (1997)J. Neurophysiol. 78, 187-198.
42. Midtgaard, J. (1994) Trends Neurosci. 17, 166-173.
43. Yuste, R. & Tank, D. W. (1996) Neuron 16, 701-716.
44. Stuart, G. & Sakmann, B. (1995) Neuron 15, 1065-1076.
45. Goldman-Rakic, P. S. (1987) in Handbook of Physiology, eds. Plum, F. & Mountcastle, V. (Am. Physiol. Soc., Bethesda, MD), Vol. 5, pp. 373-414.
46. Lubow, R. E. (1973) Psychol. Bull. 79, 398-407.
47. Lubow, R. E. (1989) Latent Inhibition and Conditioned Attention Theory (Cambridge Univ. Press, Cambridge, U.K.).
48. Mackintosh, N. J. (1983) Conditioning and Associative Learning (Oxford Univ. Press, London).
49. Goldman-Rakic, P. S. & Seleman, L. D. (1997) Schizophrenia Bull. 23, 437-458.
50. Baruch, I., Hemsley, D. R. & Gray, J. A. (1988) J. Nerv. Ment. Dis. 176, 598-606.
51. Cassaday, H. J., Hodges, H. & Gray, J. A. (1993) J. Psychopharmacol. 7, 63-71.